CHIPS Quantum Funding Backs D-Wave, Rigetti, Quantinuum
Commerce finalized CHIPS quantum funding, taking minority equity stakes and tying milestone tranches that raise execution risk and dilution.
KEY TAKEAWAYS
- Commerce finalized $300 million CHIPS quantum funding for D-Wave, Rigetti, and Quantinuum.
- Rigetti Form 8-K shows milestone tranches of $43.9M, $29.9M and $26.2M and a 7,739,938-share issuance at $12.92.
- Commerce took minority, non-controlling equity stakes, creating execution-linked funding risk and potential dilution.
HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX
Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.
The Commerce Department finalized CHIPS quantum funding on Sept. 8, 2026, awarding a $300 million package that allocates up to $100 million each to D‑Wave, Rigetti, and Quantinuum. The funding aims to accelerate U.S. quantum-hardware research and manufacturing while securing minority, non-controlling equity stakes in the companies.
Funding Terms and Equity Stakes
The awards were issued under the CHIPS and Science Act through the CHIPS Research and Development Office Broad Agency Announcement. They use Other Transaction Agreements (OTAs), a flexible research-and-development vehicle that ties disbursements to milestone completion.
Rigetti’s Form 8-K, filed Sept. 8, 2026, describes an OTA dated Sept. 4, 2026, establishing a milestone-based tranche schedule. An initial tranche of $43.9 million is available on or soon after the award date, with two subsequent tranches of $29.9 million and $26.2 million contingent on Commerce’s milestone approval. The filing also details a Securities Issuance Agreement under which Rigetti will issue 7,739,938 shares to Commerce at an implied price of $12.92 per share, forming the government’s minority, non-controlling equity stake. Later tranches may be withheld if milestones are unmet.
D‑Wave announced a definitive agreement with Commerce to advance superconducting annealing and gate-model R&D and strengthen domestic quantum capacity. The company’s technical targets include developing a 100,000-qubit annealing system and a 10,000-qubit gate-model system designed to enable roughly 100 logical qubits capable of over one million operations. SEC exhibits show the agreement is governed by an OTA dated Sept. 4, with milestone-based disbursements starting with an initial tranche of about $53.6 million.
Quantinuum finalized an agreement with Commerce’s CHIPS Research and Development Office to advance trapped-ion quantum-computer manufacturing in the U.S. It is the only trapped-ion architecture recipient in this round of CHIPS awards. Quantinuum will partner with GlobalFoundries to fabricate next-generation ion traps and control electronics on 300mm wafers and with Monarch Quantum to develop and manufacture integrated lasers and optical components.
Policy Context and Program Scale
These awards formalize part of a broader CHIPS quantum initiative that began with letters of intent in May 2026 totaling about $2.013 billion across nine companies focused on quantum chip manufacturing and computing. They complement other CHIPS R&D agreements, such as GlobalFoundries’ separate $375 million deal over five years to support scaling quantum chip fabrication, cryogenic control circuits, advanced packaging, and interconnects.
Commerce’s approach combines milestone-triggered funding with federal minority equity stakes, a structure intended to enhance taxpayer return. The tranche mechanics and equity issuance disclosed in Rigetti’s filing make the tradeoffs explicit: milestone performance governs payment timing, and the government’s equity stakes provide a route to recapture value if projects advance. For recipients and shareholders, this creates execution-linked funding risk and potential dilution from the equity issuance, even as it injects capital to accelerate hardware scale-up.
